Duffau H. Diffuse Low-Grade Gliomas in Adults. 2nd ed. Duffau Ed, 2017. Springer International Publishing: Imprint: Springer; 2017. https://doi.org/10.1007/978-3-319-55466-2

Ng S, Duffau H. Brain plasticity profiling as a key support to therapeutic decision-making in low-Grade Glioma Oncological Strategies. Cancers. 2023;15:3698. https://doi.org/10.3390/cancers15143698.

Article  PubMed  PubMed Central  Google Scholar 

Ng S, Rigau V, Moritz-Gasser S, Gozé C, Darlix A, Herbet G, Duffau H. Long-term autonomy, professional activities, cognition, and overall survival after awake functional-based surgery in patients with IDH-mutant grade 2 gliomas: a retrospective cohort study. Lancet RH Europe, in press. This is the first experience ever reported with a median OS beyond 20 years and with a long-term preservation of an active life in a large cohort of 600 patients with IDH-mutated grade 2 gliomas.

Weller M, van den Bent M, Preusser M, le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18:170–86. https://doi.org/10.1038/s41571-020-00447-z.

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the Central Nervous System: a Summary. Neurooncology. 2021;23:1231–51. https://doi.org/10.1093/neuonc/noab106.

Article  CAS  Google Scholar 

European Low-Grade Glioma Network. Evidence-based management of adult patients with diffuse glioma. Lancet Oncol. 2017;18:e429. doi: 10.1016/S1470-2045(17)30510-7. Epub 2017 Jul 26. PMID: 28759376.

Chanbour H, Chotai S. Review of intraoperative adjuncts for maximal safe resection of Gliomas and its impact on outcomes. Cancers (Basel). 2022;14:5705. https://doi.org/10.3390/cancers14225705.

Article  CAS  PubMed  Google Scholar 

Jiang S, Chai H, Tang Q. Advances in the intraoperative delineation of malignant glioma margin. Front Oncol. 2023;13:1114450. https://doi.org/10.3389/fonc.2023.1114450. eCollection 2023.

Bin-Alamer O, Abou-Al-Shaar H, Gersey ZC, Huq S, Kallos JA, McCarthy DJ, et al. Intraoperative Imaging and Optical Visualization Techniques for Brain Tumor Resection: a narrative review. Cancers (Basel). 2023;15:4890. https://doi.org/10.3390/cancers15194890.

Article  PubMed  Google Scholar 

Duffau H, Filippi M. Moving towards a connectomic view of neuro-oncology. Lancet Neurol. 2024;23:655–56. https://doi.org/10.1016/S1474-4422(23)00291-0.

Article  PubMed  Google Scholar 

Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases. J Neurosurg. 2013;118:1157–68. https://doi.org/10.3171/2013.1.JNS121.

Article  PubMed  Google Scholar 

Hervey-Jumper SL, Zhang Y, Phillips JJ, Morshed RA, Young JS, McCoy L, et al. Interactive effects of Molecular, Therapeutic, and patient factors on outcome of diffuse low-Grade Glioma. J Clin Oncol. 2023;41:2029–42. https://doi.org/10.1200/JCO.21.02929.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verdier M, Deverdun J, de Champfleur NM, Duffau H, Lam P, et al. Evaluation of a nnu-net type automated clinical volumetric tumor segmentation tool for diffuse low-grade glioma follow-up. J Neuroradiol. 2024;51:16–23. https://doi.org/10.1016/j.neurad.2023.05.008.

Article  PubMed  Google Scholar 

Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg. 2010;112:10–7. https://doi.org/10.3171/2008.10.JNS08608.

Article  PubMed  Google Scholar 

Rossi M, Gay L, Ambrogi F, Conti Nibali M, Sciortino T, Puglisi G, et al. Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas. Neuro Oncol. 2021;23:812–26. https://doi.org/10.1093/neuonc/noaa225.

Article  PubMed  Google Scholar 

Duffau H, Pallud J, Mandonnet E. Evidence for the genesis of WHO grade II glioma in an asymptomatic young adult using repeated MRIs. Acta Neurochir (Wien). 2011;153:473–7. https://doi.org/10.1007/s00701-010-0917-x.

Article  PubMed  Google Scholar 

Gerin C, Pallud J, Grammaticos B, Mandonnet E, Deroulers C, Varlet P, et al. Improving the time-machine: estimating date of birth of grade II gliomas. Cell Prolif. 2012;45:76–90. https://doi.org/10.1111/j.1365-2184.2011.00790.x.

Article  CAS  PubMed  Google Scholar 

Mandonnet E, Pallud J, Fontaine D, Taillandier L, Bauchet L, Peruzzi P, et al. Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev. 2010;33(1):91–6. https://doi.org/10.1007/s10143-009-0229-x.

Article  PubMed  Google Scholar 

Duffau H. Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up. Acta Neurochir (Wien). 2016;158:51–8. https://doi.org/10.1007/s00701-015-2621-32.

Article  PubMed  Google Scholar 

Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, et al. Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. Neuro Oncol. 2013;15:595–606. https://doi.org/10.1093/neuonc/nos331.

Article  PubMed  PubMed Central  Google Scholar 

Gozé C, Blonski M, Le Maistre G, Bauchet L, Dezamis E, Page P, et al. Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas. Neuro Oncol. 2014;16:1100–9. https://doi.org/10.1093/neuonc/nou085.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mandonnet E. Tumor volume growth as surrogate endpoint in IDH-mt Glioma-Letter. Clin Cancer Res. 2024;30:638. https://doi.org/10.1158/1078-0432.CCR-23-3444.

Article  PubMed  Google Scholar 

Darlix A, Rigau V, Fraisse J, Gozé C, Fabbro M, Duffau H. Postoperative follow-up for selected diffuse low-grade gliomas with WHO grade III/IV foci. Neurology. 2020;94:e830-41. https://doi.org/10.1212/WNL.0000000000008877. This is the first study reporting a 5-year survival rate of 95% in patients who did not receive immediate adjuvant treatment after maximal resection for a low-grade glioma with foci of malignant transformation.

Blonski M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M, et al. Initial PCV chemotherapy followed by Radiotherapy is Associated with a prolonged response but late neurotoxicity in 20 diffuse low-Grade Glioma patients. Front Oncol. 2022;12:827897. https://doi.org/10.3389/fonc.2022.827897. The authors showed that in low-grade glioma patients treated by PCV followed by radiotherapy, after a long-term follow-up, substantial neurotoxicity was noticed with dementia in 30% of progression-free patients.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Perri D, Jmil S, Lawson TM, Van Calster L, Whenham N, Renard L. Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy. Cancer Radiother. 2023;27:219–24. https://doi.org/10.1016/j.canrad.2022.10.004.

Article  PubMed  Google Scholar 

Desmurget M, Bonnetblanc F, Duffau H. Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain. 2007;130:898–914. https://doi.org/10.1093/brain/awl300.

Article  PubMed  Google Scholar 

Ng S, Duffau H, Herbet G. Perspectives in human brain plasticity sparked by glioma invasion: from intraoperative (re)mappings to neural reconfigurations. Neural Regen Res. 2024;19:947–48. https://doi.org/10.4103/1673-5374.382246.

Article  PubMed  Google Scholar 

Ng S, Moritz-Gasser S, Lemaitre AL, Duffau H, Herbet G. Multivariate mapping of low-resilient neurocognitive systems within and around low-grade gliomas. Brain. 2024 Apr 24:awae130. doi: 10.1093/brain/awae130. Online ahead of print. This series shed new light on both low-resilient neural systems and the prediction of cognitive recovery following glioma surgery, especially after supratotal resection.

Duffau H. White matter tracts and diffuse Lower-Grade gliomas: the pivotal role of myelin plasticity in the Tumor Pathogenesis, infiltration patterns, functional consequences and Therapeutic Management. Front Oncol. 2022;12(855587). https://doi.org/10.3389/fonc.2022.855587. eCollection 2022.

Fahlström M, Mirza S, Alberius Munkhammar Å, Zetterling M, Latini F. Qualitative and visual along-tract analysis of diffusion-based parameters in patients with diffuse gliomas. Brain Sci. 2024;14:213. https://doi.org/10.3390/brainsci14030213.

Article  PubMed  PubMed Central  Google Scholar 

Darlix A, Deverdun J, Menjot de Champfleur N, Castan F, Zouaoui S, Rigau V, et al. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas. J Neurooncol. 2017;133:37–45. https://doi.org/10.1007/s11060-017-2421-0.

Article  CAS  PubMed  Google Scholar 

Alfonso JCL, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, et al. The biology and mathematical modelling of glioma invasion: a review. J R Soc Interface. 2017;14:20170490. https://doi.org/10.1098/rsif.2017.0490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez H. Quantitative analysis of the proliferative-to-invasive transition of hypoxic glioma cells. Integr Biol (Camb). 2017;9:257–62. https://doi.org/10.1039/c6ib00208k.

Article  CAS  PubMed  Google Scholar 

Budia I, Alvarez-Arenas A, Woolley TE, Calvo GF, Belmonte-Beitia J. Radiation protraction schedules for low-grade gliomas: a comparison between different mathematical models. J R Soc Interface. 2019;16:20190665. https://doi.org/10.1098/rsif.2019.0665.

Article  CAS  PubMed